The Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer

PURPOSE: To investigate the impact of targeted treatment on direct medical costs of patients with advanced non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: Medical records of 108 stage IIIB/IV NSCLC patients treated in Seoul National University Hospital between 2003 and 2009, were reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, June-Koo, Kim, Dong-Wan, Keam, Bhumsuk, Kim, Tae Min, Lee, Se-Hoon, Kim, Young-Joo, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398109/
https://www.ncbi.nlm.nih.gov/pubmed/25544584
http://dx.doi.org/10.4143/crt.2013.227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398109/
https://www.ncbi.nlm.nih.gov/pubmed/25544584
http://dx.doi.org/10.4143/crt.2013.227

Ejemplares similares